Treatment of severe COVID-19 with convalescent plasma in Bronx, NYC is a research paper published in JCI Insight (2021). On theSindex it has a DataRank of 0. It has been cited 46 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIH/National Center for Advancing Translational Service
Grant: UL1TR001073
NIH
Grant: AI 123664,AI 143453,NCATS 3UL1TR002556-04S1
Mathers Foundation
Grant: N/A
NIH
Grant: U19AI142777,R01AI32633
Albert Einstein College of Medicine
Grant: COVID-19 Pilot Award
NIH
Grant: R01-AI125462
NIH
Grant: R01AI145024
Einstein-Rockefeller-CUNY Center for AIDS Research
Grant: P30AI124414
Albert Einstein Cancer Center
Grant: P30CA013330
NIAID
Grant: R21AI141367
NIH Training Program in Cellular and Molecular Biology and Genetics
Grant: T32-GM007491
NIH Medical Scientist Training Program at Albert Einstein College of Medicine
Grant: T32-GM007288
Biomedical Advanced Research and Development Authority
Grant: 75A50120C00096
National Center for Advancing Translational Sciences
Grant: UL1TR002377
NIAID NIH HHS
Grant: R01 AI143453
NIGMS NIH HHS
Grant: T32 GM007288
NIGMS NIH HHS
Grant: T32 GM007491
NCATS NIH HHS
Grant: UL1 TR002556
NIAID NIH HHS
Grant: F30 AI150055
NIAID NIH HHS
Grant: U19 AI142777
NIAID NIH HHS
Grant: R01 AI125462
National Institutes of Health
Grant: 2P30AI124414-07
ERC Einstein-Rockefeller-CUNY Center for AIDS research
National Institutes of Health
Grant: 5T32GM007491-28
Training in Cellular and Molecular Biology and Genetics
National Institutes of Health
Grant: 1UL1TR001073-01
Clinical and Translational Science Award
National Institutes of Health
Grant: 3UL1TR002377-04S5
Mayo Clinic Center for Clinical and Translational Science (CCaTS UL1 Supplement - Dr. Regan Theiler)
National Institutes of Health
Grant: 2T32GM007288-24
MEDICAL SCIENTIST TRAINING PROGRAM
National Institutes of Health
Grant: 3P30CA013330-39S3
Core Support for Cancer Center
National Institutes of Health
Grant: 5R21AI141367-03
Plasmodium phospholipase A2s as potential novel drug targets
National Institutes of Health
Grant: 5R01AI143453-03
Antibodies, B cells and resistance to human cryptococcosis
National Institutes of Health
Grant: 1R01AI145024-01
Novel Biologics Designed to Mobilize HIV-specific CTL for Sustained HIV Remission
National Institutes of Health
Grant: 3UL1TR002556-04S1
Convalescent Plasma to Limit Coronavirus Associated Complications: A Randomized Blinded Phase 2 Study Comparing the Efficacy and Safety of Anti-SARS-CoV-2 Plasma to Placebo in COVID-19 hospitalized pa
National Institutes of Health
Grant: 5R01AI125462-04
Engineered, multispecific antibodies as broad anti-filovirus therapeutics
National Institutes of Health
Grant: 5U19AI142777-04
Prometheus: A Platform for Rapid Development of Human Antibody-based Therapeutics and Prophylactics against Emerging Viral Threats
FWCI
2.85
Citation Percentile
0.9%
Influential Citations
2
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals